Obsidian Therapeutics, Inc. (OBX)
Nasdaq: OBX · CIK 0002130606 · United States
Every official Obsidian Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open OBX filings
Obsidian Therapeutics, Inc. documents
- Obsidian Therapeutics, Inc. 10-K 2026OBX 10-K 2026: annual report for fiscal 2026
- Obsidian Therapeutics, Inc. 10-K 2025OBX 10-K 2025: annual report for fiscal 2025
- Obsidian Therapeutics, Inc. 10-K 2024OBX 10-K 2024: annual report for fiscal 2024
- Obsidian Therapeutics, Inc. 10-K 2023OBX 10-K 2023: annual report for fiscal 2023
- Obsidian Therapeutics, Inc. 10-K 2022OBX 10-K 2022: annual report for fiscal 2022
- Obsidian Therapeutics, Inc. 10-Q 2026OBX 10-Q 2026: quarterly report for fiscal 2026
- Obsidian Therapeutics, Inc. 10-Q 2025OBX 10-Q 2025: quarterly report for fiscal 2025
- Obsidian Therapeutics, Inc. 10-Q 2024OBX 10-Q 2024: quarterly report for fiscal 2024
- Obsidian Therapeutics, Inc. 10-Q 2023OBX 10-Q 2023: quarterly report for fiscal 2023
- Obsidian Therapeutics, Inc. 10-Q 2022OBX 10-Q 2022: quarterly report for fiscal 2022
- Obsidian Therapeutics, Inc. 8-K 2026OBX 8-K 2026: current report for fiscal 2026
- Obsidian Therapeutics, Inc. 8-K 2025OBX 8-K 2025: current report for fiscal 2025
- Obsidian Therapeutics, Inc. 8-K 2024OBX 8-K 2024: current report for fiscal 2024
- Obsidian Therapeutics, Inc. 8-K 2023OBX 8-K 2023: current report for fiscal 2023
- Obsidian Therapeutics, Inc. 8-K 2022OBX 8-K 2022: current report for fiscal 2022
- Obsidian Therapeutics, Inc. DEF 14A 2026OBX DEF 14A 2026: proxy statement for fiscal 2026
- Obsidian Therapeutics, Inc. DEF 14A 2025OBX DEF 14A 2025: proxy statement for fiscal 2025
- Obsidian Therapeutics, Inc. DEF 14A 2024OBX DEF 14A 2024: proxy statement for fiscal 2024
- Obsidian Therapeutics, Inc. DEF 14A 2023OBX DEF 14A 2023: proxy statement for fiscal 2023
- Obsidian Therapeutics, Inc. DEF 14A 2022OBX DEF 14A 2022: proxy statement for fiscal 2022
- Obsidian Therapeutics, Inc. Form 4 2026OBX Form 4 2026: insider trading filing for fiscal 2026
- Obsidian Therapeutics, Inc. Form 4 2025OBX Form 4 2025: insider trading filing for fiscal 2025
- Obsidian Therapeutics, Inc. Form 4 2024OBX Form 4 2024: insider trading filing for fiscal 2024
- Obsidian Therapeutics, Inc. Form 4 2023OBX Form 4 2023: insider trading filing for fiscal 2023
- Obsidian Therapeutics, Inc. Form 4 2022OBX Form 4 2022: insider trading filing for fiscal 2022
- Obsidian Therapeutics, Inc. S-1 2026OBX S-1 2026: registration statement for fiscal 2026
- Obsidian Therapeutics, Inc. S-1 2025OBX S-1 2025: registration statement for fiscal 2025
- Obsidian Therapeutics, Inc. S-1 2024OBX S-1 2024: registration statement for fiscal 2024
- Obsidian Therapeutics, Inc. S-1 2023OBX S-1 2023: registration statement for fiscal 2023
- Obsidian Therapeutics, Inc. S-1 2022OBX S-1 2022: registration statement for fiscal 2022
- Obsidian Therapeutics, Inc. 13F 2026OBX 13F 2026: institutional holdings for fiscal 2026
- Obsidian Therapeutics, Inc. 13F 2025OBX 13F 2025: institutional holdings for fiscal 2025
- Obsidian Therapeutics, Inc. 13F 2024OBX 13F 2024: institutional holdings for fiscal 2024
- Obsidian Therapeutics, Inc. 13F 2023OBX 13F 2023: institutional holdings for fiscal 2023
- Obsidian Therapeutics, Inc. 13F 2022OBX 13F 2022: institutional holdings for fiscal 2022
More companies